Co-operative Group Proposes Store Sales to Resolve Antitrust Concerns
Co-operative Group Limited has proposed divesting 15 convenience stores and two funeral homes to address regulatory competition concerns surrounding its completed acquisition of The Southern Co-operative Limited. The UK regulator has launched a public consultation to evaluate whether the proposed asset sales are sufficient to preserve local market competition.
The remedy proposal follows a warning issued on 15 September 2026 that the transaction would be subject to an in-depth investigation unless acceptable solutions were presented. By offering targeted divestments in areas where overlap created potential issues, Co-operative Group Limited aims to satisfy regulatory requirements without triggering a lengthy second-phase inquiry.
Public comments on the proposed store sales will be accepted through 27 October 2026. Regulatory authorities will consider the feedback before reaching a final determination by 24 November 2026 on whether to accept the concessions as submitted or request further changes.
Key points
- Co-operative Group Limited proposed selling 15 convenience stores and two funeral homes to resolve competition issues.
- The proposed divestments follow a regulatory warning on 15 September 2026 regarding an in-depth phase 2 inquiry.
- A public consultation regarding the sufficiency of the proposed asset sales is open until 27 October 2026.
- A final decision on whether to accept or modify the undertakings is set for 24 November 2026.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
Why is Co-operative Group selling 15 convenience stores?
Co-operative Group Limited offered to sell 15 stores and two funeral homes to address local competition concerns stemming from its acquisition of The Southern Co-operative Limited.
When will a final decision be made on the Co-op merger?
Public comments close on 27 October 2026, and regulators will decide whether to approve or modify the proposed remedies by 24 November 2026.